Free Delivery Over $100
|
|
|||
|
||||
OverviewFor the past ten years, the therapeutic management of ankylosing spondylitis (AS) has considerably changed. In fact, the introduction of anti-TNF agents in AS provides new (and until now, unmet) therapeutic perspectives for the patients. This review analyses the available data on clinical, radiological, and biological efficacy of infliximab, the first anti-tumor necrosis factor (anti-TNF) used in AS, and discusses its place in the treatment of AS. Some questions persist, notably whether this treatment has disease controlling properties. Full Product DetailsAuthor: Anas RasheedPublisher: Createspace Independent Publishing Platform Imprint: Createspace Independent Publishing Platform Dimensions: Width: 21.60cm , Height: 0.20cm , Length: 27.90cm Weight: 0.131kg ISBN: 9781517411053ISBN 10: 151741105 Pages: 32 Publication Date: 19 September 2015 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
